采纳股份9月15日获融资买入1409.42万元，融资余额7095.01万元

Group 1 - The core viewpoint of the articles highlights the financial performance and stock trading activities of Canar Technology Co., Ltd. as of mid-September 2023 [1][2] - As of September 15, 2023, Canar's stock price increased by 1.28%, with a trading volume of 97.68 million yuan [1] - The financing buy-in amount for Canar on September 15 was 14.09 million yuan, while the financing repayment was 9.35 million yuan, resulting in a net financing buy-in of 4.74 million yuan [1] - The total financing and securities lending balance for Canar reached 70.95 million yuan, accounting for 2.30% of its market capitalization, indicating a high level compared to the past year [1] - The company has a significant reliance on its main business segments, with revenue contributions of 45.17% from syringes, 45.01% from puncture needles, 5.49% from laboratory consumables, and 4.33% from other products [1] Group 2 - As of September 10, 2023, the number of shareholders for Canar increased by 4.82% to 7,769, while the average circulating shares per person decreased by 4.60% to 9,736 shares [2] - For the first half of 2025, Canar reported an operating income of 158 million yuan, a year-on-year decrease of 18.54%, and a net profit attributable to shareholders of 9.37 million yuan, down 71.78% year-on-year [2] - Since its A-share listing, Canar has distributed a total of 155 million yuan in dividends, with 122 million yuan distributed over the past three years [2]